Investigator Grant Payments

INVESTIGATOR GRANT PAYMENTS ARTICLES

INVESTIGATOR GRANT PAYMENTS WHITE PAPERS AND CASE STUDIES

INVESTIGATOR GRANT PAYMENTS PRODUCTS & SERVICES

Manage inspection-ready clinical trial documents with confidence for faster study execution with TrialKit’s electronic trial master file system.

The quality assurance (QA) team ensures the highest standards from pre-clinical to market by focusing on operational quality control, quickly identifying potential issues, and implementing necessary changes.

We aim to provide cost effective gene therapy treatments to every patient in need and take a patient first approach to industry partnerships.

PHCbi brand’s 8.1 cu.ft (230 L) Cell-IQ series CO₂ incubator features a patented Direct Heat and Air Jacket system, dual IR sensor, SafeCell™ UV, and inCu-saFe® interior to helps ensure precise temperature, CO₂ levels, and contamination control. A high-speed H₂O₂ vapor decontamination cycle completes in under three hours, supporting rapid turnaround in high-throughput labs. This stackable, medium-capacity unit is ideal for scaling up cell culture workflows and integrating with lab automation systems.

The MFBP-00084CH passive MMIC bandpass filter die is an ideal solution for small form factor, high rejection filtering.

PHCbi brand's 5.0 cu.ft. (142 L) undercounter refrigerator features precise temperature control engineered to meet the current and evolving criteria included in guidelines for critical storage. Energy efficient by design it is ENERGY STAR® Certified.

The MFBT-00003PSM is a surface mount MMIC tunable filter for adaptive filtering applications that offers separate low pass and high pass tuning capabilities.

Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.

INVESTIGATOR GRANT PAYMENTS NEWS

ABOUT

Investigator Grant Payments
In the clinical trials industry, there is usually the pressure of making profits while maintaining regulatory compliance. In order to maximize on their research and development spending, pharmaceutical companies are reducing clinical trial cycle times.
However, there are an increasing number of clinical trials, with more complex protocols and more stringent regulatory requirements. Despite all these, many sponsors issue late payments to investigative sites, and many of these sites are struggling to maintain financial viability.
If the sponsors want to maintain strong, effective investigative sites, they need to build strong relationships with them. This involves coming up with a more effective approach to investigator grant payments. This will not only improve investigator relationships and satisfaction, it will help sponsors to accelerate cycle times and reduce the costs of clinical trials.
First, there is a need to understand that accounts payable in the clinical trials industry are very complex. Investigator grant payments are driven by the terms of the clinical trial agreement. These agreements are highly complex documents with various variables that can impact on the grant payment.
There is also a need for better management of investigator grant payments through the right personnel. Apart from having a background in finance and accounting, those in charge ought to have some experience in financial management of clinical trials.
Such a person would understand the standard process for a clinical trial, from screening to treatment of patients. He or she should be able to read and understand how the clinical study is progressing against the clinical trial agreement.